Related Experiment Video
Updated: May 21, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Adjunctive therapy in community-acquired pneumonia.
Richard G Wunderink1, Lionel Mandell
1Department of Medicine, Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, 676 North St. Clair, Chicago, IL 60611, USA. r-wunderink@northwestern.edu
Adjunctive therapies for community-acquired pneumonia (CAP) are being explored. While macrolides show promise, evidence for corticosteroids and NSAIDs is limited, necessitating further research into host-response treatments for severe CAP.
Area of Science:
- Infectious Diseases
- Pulmonology
- Pharmacology
Background:
- Community-acquired pneumonia (CAP) is a leading cause of death in the US, despite antibiotic use.
- There is a need for adjunctive therapies targeting the host response in severe CAP.
- Understanding host response pathways is crucial for improving CAP outcomes.
Purpose of the Study:
- To review current adjunctive therapies for severe community-acquired pneumonia.
- To evaluate the potential role of immunomodulatory agents and other host-directed treatments.
- To identify areas for future research in CAP management.
Main Methods:
- Literature review of existing studies on adjunctive therapies for CAP.
- Analysis of evidence for macrolide antibiotics, corticosteroids, NSAIDs, statins, and anticoagulation agents.
- Assessment of theoretical benefits and clinical trial status of novel therapies.
Main Results:
- Macrolide antibiotics may offer immunomodulatory benefits in severe CAP.
- Corticosteroids lack clear demonstrated benefit, requiring larger trials.
- NSAIDs may improve oxygenation but not mortality; statin use before diagnosis shows benefit.
- Anticoagulation therapies (drotrecogin alfa, tifacogin) have not shown survival benefits.
Conclusions:
- Adjunctive therapies targeting host response are attractive for severe CAP management.
- Further research is needed for corticosteroids, statins initiated at diagnosis, and other novel agents.
- Current evidence suggests limited benefit from NSAIDs and anticoagulation therapies for mortality reduction in CAP.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation